HERON THERAPEUTICS, INC. /DE/ — Director's Dealing 2016

Dec 23, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HERON THERAPEUTICS, INC. /DE/ (HRTX)
CIK: 0000818033
Period of Report: 2016-12-21

Reporting Person: Johnson Craig A (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-12-21	Stock Option (Right to Buy)	$13.00	A	21000	Acquired	2026-12-21	Common Stock (21000)	Direct

Footnotes

F1: The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant.